VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 229 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $964,173 | -63.5% | 102,900 | -4.6% | 0.01% | -61.5% |
Q2 2023 | $2,644,898 | +121.5% | 107,823 | +110.2% | 0.03% | +116.7% |
Q1 2023 | $1,193,914 | -17.1% | 51,307 | -9.8% | 0.01% | -20.0% |
Q4 2022 | $1,440,215 | +163.8% | 56,903 | +101.0% | 0.02% | +150.0% |
Q3 2022 | $546,000 | – | 28,308 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |